Adjuvant CMFVP versus tamoxifen evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptor positive tumours - Rifkin,S.E.; Green,S.; Metch,B. (J Clin Oncol, 1994)